KILL Mydecine Innovations Group Announces C$10 Million Bought Deal Offering of Units

KILL Mydecine Innovations Group Announces C$10 Million Bought Deal Offering of Units

 

–(BUSINESS WIRE)–
Miller Thomson LLP requests that their press release NewsItemId: 20210120005542 “Mydecine Innovations Group Announces C$10 Million Bought Deal Offering of Units” be killed.

The release was issued by Miller Thomson LLP without prior authorization from Mydecine Innovations Group.

Mydecine Innovations Group Media Contacts

Anne Donohoe / Nick Opich

KCSA Strategic Communications

[email protected] / [email protected]

212-896-1265 / 212-896-1206

On behalf of the Board of Directors:

Joshua Bartch, Chief Executive Officer

[email protected]

Corp Communications:

Charles Lee, Investor Relations

[email protected]

+1 720-277-9879

KEYWORDS: United States North America Ohio

INDUSTRY KEYWORDS: Biotechnology Mental Health Health Science Research

MEDIA: